BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2804917)

  • 1. Possible disorder of B-cell-related surveillance and malignant lymphoma of the thyroid.
    Matsubayashi S; Tamai H; Morita T; Matsuzuka F; Kuma K; Miyazaki T; Matsumoto H; Nagataki S; Volpé R
    Cancer; 1989 Dec; 64(11):2259-61. PubMed ID: 2804917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA Gm systems and susceptibility to alcoholic cirrhosis: a study of mixed-race subjects.
    Poupon RE; Heintzmann F; Valette I; Gervaise G; Edouard A; Monplaisir N; Dugoujon JM
    Alcohol Alcohol; 1991; 26(4):417-24. PubMed ID: 1760053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoglobulin allotype Gm(1,2;21) in ankylosing spondylitis with peripheral arthritis.
    Mierau R; von Mühlen CA; Zarnowski H; Genth E; Hartl PW
    Ann Rheum Dis; 1988 Nov; 47(11):893-7. PubMed ID: 3264692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA A, B, and DR antigens and complotype in Tunisian patients with diabetes mellitus.
    Ayed K; Bardi R; Gorgi Y; Jenhani F; Chammakhi S; Boukhris R
    Dis Markers; 1989; 7(1):43-7. PubMed ID: 2714046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphisms in HLA-A, -B, -C and -DR antigens in Japanese patients with palmoplantar pustulosis.
    Torii H; Nakagawa H; Ishibashi Y; Tokunaga K; Juji T
    Dermatology; 1994; 188(4):290-2. PubMed ID: 8193402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevalence of HLA antigens in patients with myocardial infarction and unstable stenocardia].
    Borovkov NN; Dobrotina NA; Kazakova IM; Kopytova TV; Sidorova TI
    Kardiologiia; 1992 Jan; 32(1):21-2. PubMed ID: 1535391
    [No Abstract]   [Full Text] [Related]  

  • 7. HLA-A, B, C antigens in pulmonary sarcoidosis in Polish population.
    Dubaniewicz A; Szczerkowska Z
    Arch Immunol Ther Exp (Warsz); 1999; 47(1):55-9. PubMed ID: 11729830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-A,B,C, and DR antigens in recurrent oral ulcers.
    Albanidou-Farmaki E; Kayavis IG; Polymenidis Z; Papanayotou P
    Ann Dent; 1988; 47(1):5-8, 15. PubMed ID: 3178134
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies of histocompatibility antigens in otospongiosis].
    Buczyłko K; Latkowski B; Miekoś L; Kaczmarek A
    Otolaryngol Pol; 1988; 42(5):333-7. PubMed ID: 3253645
    [No Abstract]   [Full Text] [Related]  

  • 10. HLA antigens in primary fibromyalgia syndrome.
    Hørven S; Stiles TC; Holst A; Moen T
    J Rheumatol; 1992 Aug; 19(8):1269-70. PubMed ID: 1404164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective and non-selective loss of immunoregulatory molecules (HLA-A,B,C antigens and LFA-3) in transitional cell carcinoma.
    Nouri AM; Smith ME; Crosby D; Oliver RT
    Br J Cancer; 1990 Oct; 62(4):603-6. PubMed ID: 1699592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [HLA histocompatibility antigens in patients with aortic valve defects].
    Waszyrowski T; Zebrowski A; Krzemińska-Pakuła M; Miś J; Kaczmarek A
    Kardiol Pol; 1991; 35(7):27-30. PubMed ID: 1942751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human leukocyte antigens -A, -B, -C, and -DR and nasopharyngeal carcinoma in northern China.
    Zhu XN; Chen R; Kong FH; Liu W
    Ann Otol Rhinol Laryngol; 1990 Apr; 99(4 Pt 1):286-7. PubMed ID: 2327697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of IgG heavy-chain allotypes (Gm) with Graves' disease in Hungary.
    Kozma L; Stenszky V; Kraszits E; Balazs C; Farid NR
    Exp Clin Immunogenet; 1985; 2(3):154-7. PubMed ID: 3939975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of IgG heavy-chain allotypes (Gm) and HLA in conferring susceptibility to thyroid carcinoma.
    Juhasz F; Balazs G; Kozma L; Kraszits E; Stenszky V; Farid NR
    Clin Endocrinol (Oxf); 1986 Jul; 25(1):17-21. PubMed ID: 3791655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgG heavy chain allotype (Gm), a genetic marker for human chromosome 14q32, and haematopoietic malignancies.
    Nakao Y; Matsumoto H; Tsuji K; Miyazaki T; Masaoka T; Nakayama S; Kinoshita K; Shingami T; Matsui T; Fujita T
    Clin Exp Immunol; 1984 Jun; 56(3):628-36. PubMed ID: 6430611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency analysis of HLA class I alleles in Iranian patients with progressive and non-progressive chronic lymphocytic leukemia.
    Hojjat-Farsangi M; Razavi SM; Sharifian RA; Shokri F
    Hum Immunol; 2014 Feb; 75(2):170-5. PubMed ID: 24269699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gm allotypes and HLA in rheumatoid arthritis patients with circulating antibodies to native type II collagen.
    Sanders PA; Grennan DM; Klimiuk PS; Clague RB; deLange GG; Collins I; Dyer PA
    Ann Rheum Dis; 1987 May; 46(5):391-4. PubMed ID: 3496057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study on the association of HLA with malignant lymphoma.
    Xu XP; Zheng CY; Wang CY; Li QH
    Immunol Invest; 1986 Mar; 15(1):55-9. PubMed ID: 2423453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered HLA antigens expressed on T and B lymphocytes of adult T-cell leukemia/lymphoma patients and their relatives.
    Sonoda S; Yashiki S; Takahashi K; Arima N; Daitoku Y; Matsumoto M; Matsumoto T; Tara M; Shinmyozu K; Sato K
    Int J Cancer; 1987 Nov; 40(5):629-34. PubMed ID: 2890588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.